esophageal cancer
Esophageal Cancer Molecular Study Highlights Tumor Subtypes, Treatment Response Markers
Researchers found four esophageal squamous cell carcinoma molecular subtypes by generating genomic, transcriptomic, epigenetic, and proteomic profiles for more than 150 cases.
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
The company reported a record number of tests in the quarter led by its skin cancer menu but with notable sales in other test categories.
Immuno-Genomic Features Predict Treatment Response in Esophageal Carcinoma
Researchers developed a machine learning tool that combines the features to predict response to platinum-based neoadjuvant chemotherapy.
QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International
Under the agreement, Proteomics International has the right to use the markers to develop and commercialize a blood-based early detection test for esophageal cancer.